Barts Cancer Institute, Queen Mary University of London, London, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
BJU Int. 2018 Apr;121(4):575-582. doi: 10.1111/bju.14056. Epub 2017 Nov 12.
To investigate the pathology of excised testicular lesions <10 mm in size.
The pathological reports of 2 681 patients with testicular lesions from Barts Health NHS Trust and Oxford University Hospitals NHS Foundation Trust were reviewed as part of a service evaluation audit from January 2003 to May 2016. Cases in which the lesion had a maximum diameter of <10 mm were selected. Clinical features were also accessed, where available, to examine patient demographics, prediagnostic levels of serum markers, ultrasonographic findings and clinical details.
A total of 81 patients with a lesion size <10 mm on histology were identified and, of these, 16 (20%) had a lesion diameter <5 mm. Of the 81 patients, 56 (69%) had benign lesions. Of 16 patients with a benign lesion <5 mm in diameter, 15 underwent orchidectomy and just one underwent partial orchidectomy. Preoperative tumour markers were available in 47/81 patients. None of the 16 malignant tumours in these 47 patients were associated with raised tumour markers, while seven of 31 remaining patients with benign lesions had raised α-fetoprotein and lactate dehydrogenase levels. In total there were 25/81 malignant cases (31%), which were all germ cell tumours (GCTs): 15 seminomas (60%) and 10 non-seminomatous GCTs (40%). Only one GCT had a diameter of <5 mm, and this was a regressed tumour within an 18-mm area of granulomatous inflammation. Only one GCT relapsed: a clinical stage I, embryonal carcinoma of 6 mm in maximum diameter. The 56 'benign' cases included 34 sex cord stromal tumours, including 23 Leydig cell tumours (41%), eight Sertoli cell tumours (14%) and three mixed sex cord stromal tumours (5%). None showed any malignant features. The remaining 22/56 lesions (40%) were lesions with no further follow-up. Benign lesions seemed to be associated with a small diameter, and we found <5 mm to be the best threshold for predicting benign vs malignant lesions (P = 0.002).
The majority of testicular lesions <10 mm, identified by radiology, were benign, although approxmiately one-third were malignant. In the present study, 100% of lesions <5 mm in diameter were benign. Tumour markers appear to be unhelpful in the distinction of these small tumours. We suggest that regular ultrasound surveillance be more widely used for testicular lesions of this size. Testicular tumours now have a very high cure rate and changes in size of lesions may be monitored prospectively with minimal risk of increased morbidity. Patients who undergo an orchidectomy for lesions <5 mm are 'victims of modern imaging technology'. If surgery is undertaken in lesions 5-10 mm, patients should be counselled that two-thirds of cases are benign.
研究 <10 毫米大小的切除睾丸病变的病理学。
作为服务评估审计的一部分,对 2003 年 1 月至 2016 年 5 月期间巴特西健康国民保健制度信托基金会和牛津大学医院国民保健制度基金会的 2681 名睾丸病变患者的病理报告进行了回顾。选择病变最大直径 <10 毫米的病例。还查阅了临床特征,在可用的情况下检查患者人口统计学、诊断前血清标志物水平、超声发现和临床细节。
共确定了 81 名组织学上病变大小 <10 毫米的患者,其中 16 名(20%)病变直径 <5 毫米。在 81 名患者中,56 名(69%)为良性病变。在 16 名直径 <5 毫米的良性病变患者中,15 名接受了睾丸切除术,只有 1 名接受了部分睾丸切除术。在 81 名患者中有 47 名患者可获得术前肿瘤标志物。在这些 47 名患者中,没有 16 名恶性肿瘤患者的肿瘤标志物升高,而在其余 31 名良性病变患者中,有 7 名患者的α-胎蛋白和乳酸脱氢酶水平升高。共有 25/81 例恶性病例(31%)为生殖细胞瘤(GCT):15 例精原细胞瘤(60%)和 10 例非精原细胞瘤 GCT(40%)。只有一个 GCT 的直径 <5 毫米,这是一个在 18 毫米面积的肉芽肿性炎症内的退行性肿瘤。只有一个 GCT 复发:一个最大直径为 6 毫米的临床 I 期胚胎癌。56 例“良性”病例包括 34 例性索间质肿瘤,其中 23 例为 Leydig 细胞瘤(41%),8 例 Sertoli 细胞瘤(14%)和 3 例混合性索间质肿瘤(5%)。均无恶性特征。其余 22/56 例病变(40%)无进一步随访。良性病变似乎与小直径有关,我们发现 <5 毫米是预测良性与恶性病变的最佳阈值(P = 0.002)。
放射学发现的 <10 毫米的大多数睾丸病变为良性,尽管约三分之一为恶性。在本研究中,所有直径 <5 毫米的病变均为良性。肿瘤标志物似乎无助于区分这些小肿瘤。我们建议更广泛地使用常规超声监测这些大小的睾丸病变。睾丸肿瘤现在的治愈率非常高,病变大小的变化可以前瞻性地监测,风险极小,发病率增加。对于直径 <5 毫米的病变进行睾丸切除术的患者是“现代影像学技术的受害者”。如果对 5-10 毫米的病变进行手术,应告知患者三分之二的病例为良性。